Inogen, Inc. (INGN)
NASDAQ: INGN · Real-Time Price · USD
9.03
+0.34 (3.91%)
Nov 4, 2024, 4:00 PM EST - Market closed
Inogen Employees
Inogen had 834 employees as of December 31, 2023. The number of employees decreased by 192 or -18.71% compared to the previous year.
Employees
834
Change (1Y)
-192
Growth (1Y)
-18.71%
Revenue / Employee
$391,670
Profits / Employee
-$110,842
Market Cap
214.18M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Nevro | 1,215 |
Adaptimmune Therapeutics | 449 |
Nanobiotix | 102 |
Kyverna Therapeutics | 96 |
Semler Scientific | 92 |
PepGen | 64 |
Cybin | 50 |
Corbus Pharmaceuticals Holdings | 19 |
INGN News
- 1 day ago - Inogen to Present at Upcoming Investor Conferences - Business Wire
- 19 days ago - Inogen to Report Third Quarter 2024 Financial Results on November 7, 2024 - Business Wire
- 4 weeks ago - Inogen Launches Rove 4 Portable Oxygen Concentrator, Delivering the Highest Oxygen Output in the Lightest Weight 4-Setting POC - Business Wire
- 2 months ago - Inogen Appoints Eric Pauls as Vice President of Sales, North America - Business Wire
- 3 months ago - Inogen, Inc. (INGN) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Inogen Announces Second Quarter 2024 Financial Results - Business Wire
- 4 months ago - Inogen to Report Second Quarter 2024 Financial Results on August 6, 2024 - Business Wire
- 4 months ago - Inogen Strengthens Leadership Team with Appointment of New General Counsel and Executive Vice President, Business Development - Business Wire